Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) YoY EBITDA Growth : 0.00% (As of . 20)

View and export this data going back to 2009. Start your Free Trial

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Pharmedic Pharmaceutical Medicinal Joint Stock Company's YoY EBITDA Growth for the quarter that ended in . 20 was 0.00%.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's EBITDA per Share for the three months ended in . 20 was ₫0.00.

Pharmedic Pharmaceutical Medicinal Joint Stock Company YoY EBITDA Growth Historical Data

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmedic Pharmaceutical Medicinal Joint Stock Company YoY EBITDA Growth Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data

Trend

YoY EBITDA Growth

Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data

YoY EBITDA Growth

Pharmedic Pharmaceutical Medicinal Joint Stock Company YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's YoY EBITDA Growth for the fiscal year that ended in . 20 is calculated as:

	YoY EBITDA Growth (A: . 20 )
=	(EBITDA per Share (A: . 20 )	-	EBITDA per Share (A: . 20 ))	/	\| EBITDA per Share (A: . 20 ) \|
=	(	-	)	/	\| \|
=	N/A %

Pharmedic Pharmaceutical Medicinal Joint Stock Company's YoY EBITDA Growth for the quarter that ended in . 20 is calculated as:

	YoY EBITDA Growth (Q: . 20 )
=	(EBITDA per Share (Q: . 20 )	-	EBITDA per Share (Q: . 20 ))	/	\| EBITDA per Share (Q: . 20 )) \|
=	(	-	)	/	\| \|
=	N/A %

Pharmedic Pharmaceutical Medicinal Joint Stock Company YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Pharmedic Pharmaceutical Medicinal Joint Stock Company's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

N/A

Address

367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM

Website

https://www.pharmedic.com.vn

Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, pharmaceuticals, cosmetics, medical supplies, and other products in the health sector.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Headlines

From GuruFocus

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor • 08-13-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 08-05-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-04-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor • 11-16-2009

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk • 06-25-2012